tiprankstipranks
Mesoblast Limited (AU:MSB)
ASX:MSB

Mesoblast Limited (MSB) Similar Shares

76 Followers

Other Large Cap Stocks Paying Dividends

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mesoblast Limited
$907.39M
-7.42
-6.82%
0 Buy
1 Hold
0 Sell
Hold
Sarepta Therapeutics
$14.08B
2,240.30
37.78%
14 Buy
4 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$5.33B
-23.05
4.73%
9 Buy
6 Hold
1 Sell
Moderate Buy
Vericel
$2.54B
-9,852.83
33.06%
6 Buy
0 Hold
0 Sell
Strong Buy
Alnylam Pharma
$31.60B
-93.13
15.16%
14 Buy
6 Hold
0 Sell
Moderate Buy
Mesoblast Limited
AU$1.33B
-7.42
-6.82%
0 Buy
1 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
MEOBF
Mesoblast Limited
0.82
-0.08
-8.89%
SRPT
Sarepta Therapeutics
146.90
40.99
38.70%
CRSP
Crispr Therapeutics AG
60.48
2.36
4.06%
VCEL
Vericel
51.72
12.47
31.77%
ALNY
Alnylam Pharma
240.02
34.70
16.90%
AU:MSB
Mesoblast Limited
1.13
-0.19
-14.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis